Skip to main content

Bacteremia News

IDSA: Antibiotics for Seven Days Feasible for Patients Hospitalized With Bloodstream Infections

MONDAY, Oct. 21, 2024 – Treating hospitalized patients with bloodstream infections with antibiotics for seven days is noninferior to treating for 14 days, according to a study presented at the...

FDA Approves Zevtera (ceftobiprole medocaril sodium) for Bacteremia, Skin and Skin Structure Infections, and Pneumonia

Allschwil, Switzerland, April 04, 2024 – Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe...

Theravance Biopharma Announces FDA Approval of Expanded Label for Vibativ (telavancin)

DUBLIN, IRELAND – (Marketwired) – 05/09/16 – Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that the U.S. Food and Drug Administration (FDA)...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Bacterial Infection

Related drug support groups

metronidazole, clindamycin, Cipro, ciprofloxacin, Flagyl, vancomycin, Rocephin